These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18625390)

  • 1. Spread of cantharidin after petrolatum use resulting in a varicelliform vesicular dermatitis.
    Shah A; Treat J; Yan AC
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S54-5. PubMed ID: 18625390
    [No Abstract]   [Full Text] [Related]  

  • 2. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
    Cathcart S; Coloe J; Morrell DS
    Clin Pediatr (Phila); 2009 Mar; 48(2):161-5. PubMed ID: 18936288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of molluscum contagiosum with cantharidin: a practical approach.
    Mathes EF; Frieden IJ
    Pediatr Ann; 2010 Mar; 39(3):124-8, 130. PubMed ID: 20302243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment.
    Langley JM; Soder CM; Schlievert PM; Murray S
    Can Fam Physician; 2003 Jul; 49():887-9. PubMed ID: 12901485
    [No Abstract]   [Full Text] [Related]  

  • 5. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V; Cathcart S; Burkhart CN; Morrell DS
    Dermatol Ther; 2013; 26(6):445-51. PubMed ID: 24552407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA; Cathcart S; Morrell DS
    Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
    Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J; Morrell DS
    Pediatr Dermatol; 2009; 26(4):405-8. PubMed ID: 19689514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB; Sidbury R; Mancini AJ
    J Am Acad Dermatol; 2000 Sep; 43(3):503-7. PubMed ID: 10954663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cantharidin: a valuable office treatment of molluscum contagiosum.
    Funt TR; Mehr KA
    South Med J; 1979 Aug; 72(8):1019. PubMed ID: 472800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cantharidin therapy for molluscum contagiosum in children.
    Epstein E
    J Am Acad Dermatol; 2001 Oct; 45(4):638. PubMed ID: 11568766
    [No Abstract]   [Full Text] [Related]  

  • 12. Cantharidin topical solution (Ycanth) for molluscum contagiosum.
    Med Lett Drugs Ther; 2024 Feb; 66(1696):27-29. PubMed ID: 38412266
    [No Abstract]   [Full Text] [Related]  

  • 13. Safe and speedy cantharidin application.
    Lao M; Weissler A; Siegfried E
    J Am Acad Dermatol; 2013 Aug; 69(2):e47. PubMed ID: 23866889
    [No Abstract]   [Full Text] [Related]  

  • 14. The utility of cantharidin for the treatment of molluscum contagiosum.
    Osier E; Eichenfield LF
    Pediatr Dermatol; 2015; 32(2):295. PubMed ID: 25690255
    [No Abstract]   [Full Text] [Related]  

  • 15. Dutasteride, cantharidin, atopiclair, cetuximab, sirolimus, AC-11 and dimericine reviewed in brief.
    Scheinfeld N
    J Drugs Dermatol; 2006 Feb; 5(2):201-3. PubMed ID: 16485893
    [No Abstract]   [Full Text] [Related]  

  • 16. Cantharidin treatment of molluscum contagiosum.
    Epstein E
    Acta Derm Venereol; 1989; 69(1):91-2. PubMed ID: 2563620
    [No Abstract]   [Full Text] [Related]  

  • 17. Religious objection to cantharidin use in Jain patients.
    Patel D; Shwayder T
    Pediatr Dermatol; 2013; 30(3):389. PubMed ID: 22380659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cantharidin Topical Solution 0.7%: First Approval.
    Keam SJ
    Paediatr Drugs; 2024 Jan; 26(1):95-100. PubMed ID: 38007409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cantharidin therapy: practice patterns and attitudes of health care providers.
    Pompei DT; Rezzadeh KS; Viola KV; Lee DH; Schairer DO; Chismar LA; Cohen SR
    J Am Acad Dermatol; 2013 Jun; 68(6):1045-6. PubMed ID: 23680201
    [No Abstract]   [Full Text] [Related]  

  • 20. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
    Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.